PMC:7311890 / 24496-25227
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T175 | 9-15 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
T176 | 16-22 | Body_part | denotes | Lipids | http://purl.org/sig/ont/fma/fma67264 |
T177 | 140-145 | Body_part | denotes | lipid | http://purl.org/sig/ont/fma/fma67264 |
T178 | 594-600 | Body_part | denotes | Lipids | http://purl.org/sig/ont/fma/fma67264 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T119 | 51-59 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T120 | 285-293 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T227 | 9-15 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T317 | 140-145 | Chemical | denotes | lipid | http://purl.obolibrary.org/obo/CHEBI_18059 |
T318 | 301-307 | Chemical | denotes | lipids | http://purl.obolibrary.org/obo/CHEBI_18059 |
T319 | 436-445 | Chemical | denotes | indicator | http://purl.obolibrary.org/obo/CHEBI_47867 |
T320 | 549-555 | Chemical | denotes | lipids | http://purl.obolibrary.org/obo/CHEBI_18059 |
T321 | 663-669 | Chemical | denotes | lipids | http://purl.obolibrary.org/obo/CHEBI_18059 |
T322 | 671-691 | Chemical | denotes | glycerophospholipids | http://purl.obolibrary.org/obo/CHEBI_37739 |
T323 | 697-710 | Chemical | denotes | sphingolipids | http://purl.obolibrary.org/obo/CHEBI_26739 |
T324 | 728-730 | Chemical | denotes | S4 | http://purl.obolibrary.org/obo/CHEBI_29401 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
566 | 16-22 | Chemical | denotes | Lipids | MESH:D008055 |
567 | 51-59 | Disease | denotes | COVID-19 | MESH:C000657245 |
576 | 140-145 | Chemical | denotes | lipid | MESH:D008055 |
577 | 301-307 | Chemical | denotes | lipids | MESH:D008055 |
578 | 549-555 | Chemical | denotes | lipids | MESH:D008055 |
579 | 594-600 | Chemical | denotes | Lipids | MESH:D008055 |
580 | 663-669 | Chemical | denotes | lipids | MESH:D008055 |
581 | 671-691 | Chemical | denotes | glycerophospholipids | MESH:D020404 |
582 | 697-710 | Chemical | denotes | sphingolipids | MESH:D013107 |
583 | 285-293 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T161 | 0-59 | Sentence | denotes | Figure 2 Plasma Lipids Associated with Severity of COVID-19 |
T162 | 60-295 | Sentence | denotes | Logistic regression model with covariates BMI, age, and sex was built with each lipid to search for significant variables that could predict disease severity of subjects (i.e., healthy control, and mild, moderate, and severe COVID-19). |
T163 | 296-377 | Sentence | denotes | Only lipids with false discovery rate (FDR) <0.05 were shortlisted and presented. |
T164 | 378-528 | Sentence | denotes | Forest plots illustrate the magnitude of odds ratios with indicator of significance of the estimate in the model; ∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05. |
T165 | 529-593 | Sentence | denotes | For non-significant lipids, the estimates were plotted as zeros. |
T166 | 594-711 | Sentence | denotes | Lipids were broadly classified according to major classes of neutral lipids, glycerophospholipids, and sphingolipids. |
T167 | 712-731 | Sentence | denotes | See also Figure S4. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T509 | 16-22 | CHEBI:18059;CHEBI:18059 | denotes | Lipids |
T510 | 51-68 | SP_7 | denotes | COVID-19 Logistic |
T511 | 140-145 | CHEBI:18059;CHEBI:18059 | denotes | lipid |
T512 | 285-293 | SP_7 | denotes | COVID-19 |
T513 | 301-307 | CHEBI:18059;CHEBI:18059 | denotes | lipids |
T514 | 549-555 | CHEBI:18059;CHEBI:18059 | denotes | lipids |
T515 | 594-600 | CHEBI:18059;CHEBI:18059 | denotes | Lipids |
T516 | 663-669 | CHEBI:18059;CHEBI:18059 | denotes | lipids |
T517 | 671-691 | CHEBI:37739;CHEBI:37739 | denotes | glycerophospholipids |
T518 | 697-710 | CHEBI:26739;CHEBI:26739 | denotes | sphingolipids |
T55143 | 26-35 | CHEBI:25212;CHEBI:25212 | denotes | ociated w |
T36658 | 140-150 | CHEBI:25212;CHEBI:25212 | denotes | lipid to s |
T91890 | 233-238 | CHEBI:18059;CHEBI:18059 | denotes | e., h |
T98946 | 308-313 | CHEBI:18059;CHEBI:18059 | denotes | with |
T39180 | 333-339 | UBERON:0001969 | denotes | (FDR) |
T374 | 373-379 | UBERON:0001969 | denotes | ted. F |
T375 | 406-414 | SP_7 | denotes | magnitud |
T376 | 478-484 | UBERON:0001969 | denotes | in the |
T377 | 485-493 | CHEBI:25212;CHEBI:25212 | denotes | model; ∗ |
T378 | 517-525 | SP_7 | denotes | ∗p < 0. |
T379 | 628-633 | CHEBI:18059;CHEBI:18059 | denotes | ordin |
T380 | 648-657 | CHEBI:25212;CHEBI:25212 | denotes | ses of ne |
T381 | 718-726 | SP_7 | denotes | so Figur |